打破障碍:为增强内体逃生和治疗性输送而设计细胞外囊泡
Jihong Kim1, Yeong Ha Hwang1, Gi-Hoon Nam2
1KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul 02841, Republic of Korea; Chemical and Biological Integrative Research Center, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea.
概括
细胞外囊泡 (EVs) 显示出治疗的前景,但与细胞体输送的内体体逃生作斗争. 工程策略和新的试验正在改善临床转化这一关键步骤.
科学领域:
- 生物技术和纳米医学
- 细胞生物学 细胞生物学
- 药物输送系统 药物输送系统
背景情况:
- 细胞外囊泡 (EVs) 是天然的纳米载体,具有出色的生物相容性和组织向性.
- 治疗EV的临床应用受限于内体逃逸不良,阻碍了细胞质药物输送.
- 合成纳米粒子经常面临生物相容性和免疫反应方面的挑战.
研究的目的:
- 审查工程策略中最近取得的进展,以增强EV内体逃逸.
- 讨论新的分析方法来量化EV内体逃生效率.
- 探索未来的前景,以克服基于电动汽车的治疗开发中的障碍.
主要方法:
- 用和聚合物对电动汽车表面进行修改.
- 电动汽车的基因工程将融合蛋白和通道形成模块纳入.
- 对EV膜脂质组成的生物物理修饰.
- 开发先进的定量试验,用于内体逃生评估.
主要成果:
- 工程策略有效地增强了EV膜融合和内体细胞破坏稳定.
- 改善的内体体逃生促进了EV货物的功能性细胞质递送.
- 先进的测试可以准确量化EV内体逃生效率.
结论:
- 克服低效的内体体逃逸对于EV疗法的临床转化至关重要.
- 电动汽车工程和分析方法的持续创新将加速治疗的发展.
- 解决制造和生物障碍对于实现电动汽车全部临床潜力至关重要.
相关概念视频
Overview of Exosomes
3.5K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.5K
Vesicular Trasport: Endocytosis, Transcytosis and Exocytosis
2.8K
Vesicular transport is a cellular process that encompasses the engulfment of particles or dissolved substances by cells. It involves endocytosis, transcytosis, and exocytosis.
Endocytosis is a cellular mechanism that involves the inward folding of the cell membrane to create vesicles that capture and transport large drug molecules. This process comprises two distinct methods: pinocytosis (often referred to as "cell drinking") and phagocytosis (often referred to as "cell...
Endocytosis is a cellular mechanism that involves the inward folding of the cell membrane to create vesicles that capture and transport large drug molecules. This process comprises two distinct methods: pinocytosis (often referred to as "cell drinking") and phagocytosis (often referred to as "cell...
2.8K
Intralumenal Vesicles and Multivesicular Bodies
4.7K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
4.7K
Receptor-mediated Endocytosis
7.5K
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
7.5K


